NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Accolade Inc (NASDAQ: ACCD)
ACCD Technical Analysis
4
As on 7th Apr 2025 ACCD STOCK Price closed @ 7.02 and we RECOMMEND Sell for LONG-TERM with Stoploss of 7.88 & Strong Sell for SHORT-TERM with Stoploss of 8.81 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ACCDSTOCK Price
Open | 7.02 | Change | Price | % |
High | 7.03 | 1 Day | -0.01 | -0.14 |
Low | 7.01 | 1 Week | 0.02 | 0.29 |
Close | 7.02 | 1 Month | 0.10 | 1.45 |
Volume | 4543947 | 1 Year | 0.35 | 5.25 |
52 Week High 15.02 | 52 Week Low 3.15 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
GNLN | 0.01 | 0.00% |
NVDA | 111.61 | 2.47% |
RNAZ | 0.56 | 36.59% |
LMDX | 0.02 | 0.00% |
PLUG | 0.85 | -2.30% |
HCTI | 0.27 | 68.75% |
AKTS | 0.04 | 0.00% |
TSLA | 280.52 | -0.58% |
LCID | 2.53 | 0.80% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
ACCD Daily Charts |
ACCD Intraday Charts |
Whats New @ Bazaartrend |
ACCD Free Analysis |
|
ACCD Important Levels Intraday
RESISTANCE | 7.06 |
RESISTANCE | 7.05 |
RESISTANCE | 7.04 |
RESISTANCE | 7.03 |
SUPPORT | 7.01 |
SUPPORT | 7.00 |
SUPPORT | 6.99 |
SUPPORT | 6.98 |
ACCD Forecast May 2025
4th UP Forecast | 12.15 |
3rd UP Forecast | 10.5 |
2nd UP Forecast | 9.49 |
1st UP Forecast | 8.47 |
1st DOWN Forecast | 5.57 |
2nd DOWN Forecast | 4.55 |
3rd DOWN Forecast | 3.54 |
4th DOWN Forecast | 1.89 |
ACCD Weekly Forecast
4th UP Forecast | 8.31 |
3rd UP Forecast | 7.90 |
2nd UP Forecast | 7.64 |
1st UP Forecast | 7.39 |
1st DOWN Forecast | 6.65 |
2nd DOWN Forecast | 6.40 |
3rd DOWN Forecast | 6.14 |
4th DOWN Forecast | 5.73 |
ACCD Forecast2025
4th UP Forecast | 30.68 |
3rd UP Forecast | 23.09 |
2nd UP Forecast | 18.4 |
1st UP Forecast | 13.71 |
1st DOWN Forecast | 0.33 |
2nd DOWN Forecast | -4.36 |
3rd DOWN Forecast | -9.05 |
4th DOWN Forecast | -16.64 |
Accolade Inc ( NASDAQ USA Symbol : ACCD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ACCD Other Details
Segment | EQ | |
Market Capital | 2666567936.00 | |
Sector | Healthcare | |
Industry | Health Information Services | |
Offical website | > echo $website ; ?> |
ACCD Address
![]() |
ACCD Latest News
ACCD Business Profile
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. Address: 660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service